BMI-z scores of boys with Duchenne muscular dystrophy already begin to increase before losing ambulation: a longitudinal exploration of BMI, corticosteroids and caloric intake

•Overweight and obesity are highly prevalent in this study population of DMD patients.•Detailed, longitudinal exploration on the BMI-z course shows an increase around the period of losing ambulation, which starts already before patients become wheelchair bound.•Cross sectionally corticosteroid use w...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuromuscular disorders : NMD 2022-03, Vol.32 (3), p.236-244
Hauptverfasser: Houwen-van Opstal, Saskia L.S., Rodwell, Laura, Bot, Daphne, Daalmeyer, Anja, Willemsen, Michel A.A.P., Niks, Erik H., de Groot, Imelda J.M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Overweight and obesity are highly prevalent in this study population of DMD patients.•Detailed, longitudinal exploration on the BMI-z course shows an increase around the period of losing ambulation, which starts already before patients become wheelchair bound.•Cross sectionally corticosteroid use was associated with higher BMI-z scores and exceeding the recommended caloric intake was associated with higher BMI in non- ambulatory patients.•Although longitudinal mixed model analysis did not show significant association between BMI-z score and corticosteroid use or caloric intake, explorative analysis of the longitudinal data show that BMI-z increases before caloric intake is adjusted (often from the moment patients become wheelchair bound). Earlier intervention in caloric intake could probably help to prevent obesity. We aimed to investigate BMI-z course in patients with Duchenne muscular dystrophy (DMD) during transition to loss of ambulation, and to explore the contribution of caloric intake and corticosteroid use. A retrospective multicenter longitudinal study was conducted. First, analyses of characteristics at first visit were carried out. Second, discontinuous change models were fitted to explore associations between BMI-z, loss of ambulation, caloric intake and corticosteroid use. 790 visits of 159 patients were collected. Cross sectional first visit analyses showed the presence of overweight and obesity was 44% in the ambulant group and 51% in the non-ambulant group. In the non-ambulatory group, exceeding the recommended caloric intake was associated with higher BMI-z scores (r 0.36, p = 0.04). Patients who were using corticosteroids had significantly higher BMI-z scores compared with patients not using corticosteroids (1.06 and 0.51 respectively, p = 0.02). Longitudinal analyses on patients ambulant at first visit showed an increase in BMI-z score during transition to the non-ambulatory phase. Caloric intake and corticosteroid use were not associated with BMI-z. Transition to the non-ambulatory phase may be crucial in the development of excessive weight gain. Early measures – starting before this time frame – may contribute to reduce development of obesity.
ISSN:0960-8966
1873-2364
DOI:10.1016/j.nmd.2022.01.011